| ASCQX | VSMAX | ASCQX / VSMAX | |
| Total Expense Ratio | 0.65 | 0.05 | 1,300% |
| Annual Report Gross Expense Ratio | 0.65 | 0.05 | 1,300% |
| Fund Existence | 26 years | 25 years | - |
| Gain YTD | 13.165 | 9.847 | 134% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000000 | 3000 | 166,667% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 161M | 163B | 0% |
| Annual Yield % from dividends | 0.47 | 1.32 | 35% |
| Returns for 1 year | 11.72 | 8.23 | 142% |
| Returns for 3 years | 43.56 | 44.94 | 97% |
| Returns for 5 years | 14.38 | 36.49 | 39% |
| Returns for 10 years | 51.14 | 143.87 | 36% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ARIIX | 10.63 | 0.05 | +0.47% |
| AB Global Real Estate Investment II I | |||
| AFNAX | 24.33 | 0.10 | +0.41% |
| Bahl & Gaynor Income Growth A | |||
| VVOCX | 20.80 | 0.02 | +0.10% |
| Invesco Value Opportunities C | |||
| SHPCX | 14.12 | N/A | N/A |
| Saratoga Health & Biotechnology C | |||
| AAISX | 18.84 | -0.01 | -0.05% |
| American Beacon International Eq Adv | |||